Cytoreductive Surgery (CRS) and HIPEC for Advanced Ovarian Cancer with Peritoneal Metastases: Italian PSM Oncoteam Evidence and Study Purposes

SIMPLE SUMMARY: Ovarian cancer is still the most lethal gynecologic malignancy with a median 5-year survival of less than 50%. Most cases are diagnosed at the advanced stages and only limited improvements in overall survival are achieved by standard treatments. Despite the paucity of randomized clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Marrelli, Daniele, Ansaloni, Luca, Federici, Orietta, Asero, Salvatore, Carbone, Ludovico, Marano, Luigi, Baiocchi, Gianluca, Vaira, Marco, Coccolini, Federico, Di Giorgio, Andrea, Framarini, Massimo, Gelmini, Roberta, Palopoli, Carmen, Accarpio, Fabio, Fagotti, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740463/
https://www.ncbi.nlm.nih.gov/pubmed/36497490
http://dx.doi.org/10.3390/cancers14236010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740463/
https://www.ncbi.nlm.nih.gov/pubmed/36497490
http://dx.doi.org/10.3390/cancers14236010

Ejemplares similares